Literature DB >> 6611182

Augmentation of neutrophilic granulocyte progenitors in the bone marrow of mice with tumor-induced neutrophilia: cytochemical study of in vitro colonies.

M Y Lee, J L Lottsfeldt.   

Abstract

Transplantation of CE mammary carcinoma into mice has been shown to produce marked neutrophilia. Previous studies in vivo indicated a significant increase in marrow neutrophil production in these mice, but regulatory mechanisms of this neutrophilia have not been well understood. In order to obtain information about neutrophil production mechanisms at the progenitor cell level, the profile of marrow granulocyte-macrophage progenitors in mice with neutrophilia induced by this tumor was quantitatively analyzed by cytochemical staining of in vitro colonies to distinguish colonies of neutrophils (N-colony), macrophages (M-colony), and mixed cells (NM-colony). Cell cycle kinetics of progenitors were studied by in vivo administration of cytocidal drugs. The absolute number of N-colonies in a femur increased significantly and reached three times normal three to four weeks after tumor implantation. The number of NM-colonies also increased significantly by the fourth week, but the number of M-colonies was unchanged. The number of N-colonies in a femur related directly to the degree of neutrophilia. The increased number of N-colonies from the marrow of tumor-bearing mice was not attributed to a different time course of colony growth nor to a different sensitivity to CSA; instead, a significantly larger fraction of neutrophilic progenitors from the tumor-bearing mice were in active cell cycle than were those of normal mice. The day 14 tumor-bearing mouse serum demonstrated N-colony stimulating activity while the sera of normal mice and day 7 tumor-bearing mice were inhibitory for in vitro colony growth. These studies demonstrated an increase in the numbers and turnover rate of marrow neutrophilic progenitors in CE tumor-induced neutrophilia, suggesting that this tumor stimulates proliferation of these progenitors in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611182

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Isolation of a murine osteoclast colony-stimulating factor.

Authors:  M Y Lee; D R Eyre; W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation.

Authors:  Siddharth Jhunjhunwala; David Alvarez; Stephanie Aresta-DaSilva; Katherine Tang; Benjamin C Tang; Dale L Greiner; Peter E Newburger; Ulrich H von Andrian; Robert Langer; Daniel G Anderson
Journal:  J Leukoc Biol       Date:  2016-03-10       Impact factor: 4.962

Review 3.  Immunomethylomics: A Novel Cancer Risk Prediction Tool.

Authors:  Karl T Kelsey; John K Wiencke
Journal:  Ann Am Thorac Soc       Date:  2018-04

4.  Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.

Authors:  S Ramakrishnan; F J Xu; S J Brandt; J E Niedel; R C Bast; E L Brown
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.

Authors:  C T McGary; M E Miele; D R Welch
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

6.  Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.

Authors:  Yoon Jin Cha; Eun Jung Park; Seung Hyuk Baik; Kang Young Lee; Jeonghyun Kang
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

7.  Prediagnostic Immune Cell Profiles and Breast Cancer.

Authors:  Jacob K Kresovich; Katie M O'Brien; Zongli Xu; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  JAMA Netw Open       Date:  2020-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.